262 related articles for article (PubMed ID: 32487886)
41. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
Sung VW; Wohlrab KJ; Madsen A; Raker C
Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
[TBL] [Abstract][Full Text] [Related]
42. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
Manchana T
Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
[TBL] [Abstract][Full Text] [Related]
43. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
[TBL] [Abstract][Full Text] [Related]
44. Successful use of ring pessary with support for advanced pelvic organ prolapse.
Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
Int Urogynecol J; 2015 Oct; 26(10):1517-23. PubMed ID: 25982787
[TBL] [Abstract][Full Text] [Related]
45. Patient-Specific Pessaries for Pelvic Organ Prolapse Using Three-Dimensional Printing: A Pilot Study.
Hong CX; Zhang S; Eltahawi A; Borazjani A; Kalami H; San AN; Sham D; Ameri G; McDermott CD
Urogynecology (Phila); 2023 Sep; 29(9):732-739. PubMed ID: 36946908
[TBL] [Abstract][Full Text] [Related]
46. Pessary with perineal suture for treatment of pelvic organ prolapse: description and benefit of the technique.
Pérez-Febles M; De-Miguel-Manso S; García-García E; López-País M; Cuaresma-González M; Ibañez-Nieto M
Arch Gynecol Obstet; 2023 Mar; 307(3):789-795. PubMed ID: 36242614
[TBL] [Abstract][Full Text] [Related]
47. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study.
Thys S; Hakvoort R; Milani A; Roovers JP; Vollebregt A
Int Urogynecol J; 2021 Aug; 32(8):2159-2167. PubMed ID: 34002267
[TBL] [Abstract][Full Text] [Related]
48. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
49. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.
Lone F; Thakar R; Sultan AH
Int Urogynecol J; 2015 Sep; 26(9):1305-12. PubMed ID: 25862241
[TBL] [Abstract][Full Text] [Related]
50. Transition to surgery after pessary among female Medicare beneficiaries with pelvic organ prolapse.
Meister MRL; Osazuwa-Peters OL; Lowder JL; Handa VL
Am J Obstet Gynecol; 2023 May; 228(5):559.e1-559.e9. PubMed ID: 36627074
[TBL] [Abstract][Full Text] [Related]
51. Quality of life and vaginal symptoms of postmenopausal women using pessary for pelvic organ prolapse: a prospective study.
Coelho SCA; Marangoni-Junior M; Brito LGO; Castro EB; Juliato CRT
Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1103-1107. PubMed ID: 30569986
[TBL] [Abstract][Full Text] [Related]
52. The cube pessary: an underestimated treatment option for pelvic organ prolapse? Subjective 1-year outcomes.
Nemeth Z; Nagy S; Ott J
Int Urogynecol J; 2013 Oct; 24(10):1695-701. PubMed ID: 23579291
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of pessary fitting trials for patients with stage IV pelvic organ prolapse: a prospective study.
Zhou Y; Sun T; Ju A; Zhu L
Int Urogynecol J; 2024 Jan; 35(1):59-67. PubMed ID: 37542565
[TBL] [Abstract][Full Text] [Related]
54. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
[TBL] [Abstract][Full Text] [Related]
55. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
[TBL] [Abstract][Full Text] [Related]
56. Levator ani muscle avulsion is a risk factor for expulsion within 1 year of vaginal pessary placed for pelvic organ prolapse.
Cheung RYK; Lee JHS; Lee LL; Chung TKH; Chan SSC
Ultrasound Obstet Gynecol; 2017 Dec; 50(6):776-780. PubMed ID: 28078670
[TBL] [Abstract][Full Text] [Related]
57. Can we define excess vaginal space? - Genital hiatus size and prolapse severity are correlated with cube pessary size.
Nemeth Z; Farkas N; Farkas B
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():61-64. PubMed ID: 32791394
[TBL] [Abstract][Full Text] [Related]
58. Attitudes toward pessary use among Thai women with pelvic organ prolapse.
Mungpooklang T; Bunyavejchevin S
J Obstet Gynaecol Res; 2017 Sep; 43(9):1449-1453. PubMed ID: 28833951
[TBL] [Abstract][Full Text] [Related]
59. Ratio of Women with POP Using Pessary, Improvement in Urination and Quality of Life.
Gómez de Quero Córdoba M; Pérez JPH; Merino ÁV; Zaldibar CR; López MR; Bernal PP
Arch Esp Urol; 2022 Jun; 75(5):441-446. PubMed ID: 35983816
[TBL] [Abstract][Full Text] [Related]
60. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.
Fernando RJ; Thakar R; Sultan AH; Shah SM; Jones PW
Obstet Gynecol; 2006 Jul; 108(1):93-9. PubMed ID: 16816061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
